# Exercise Training Versus Ropinirole in Treating Restless Legs Syndrome Among Hemodialysis Patients

> **NCT06468371** · NA · COMPLETED · sponsor: **Lahore General Hospital** · enrollment: 84 (actual)

## Conditions studied

- Hemodialysis
- Restless Legs Syndrome
- ESRD (End Stage Renal Disease)
- Diabetes Complications

## Interventions

- **DRUG:** Dopamine Agonist (Ropinirole)
- **OTHER:** Excercise training

## Key facts

- **NCT ID:** NCT06468371
- **Lead sponsor:** Lahore General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-02
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-02-01
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06468371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06468371, "Exercise Training Versus Ropinirole in Treating Restless Legs Syndrome Among Hemodialysis Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06468371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*